C

The purpose of this case study on Hepatitis C (HCV) is to come up with a process improvement plan of getting patients screened, approved, educated, and started on treatment within a 20 day period. In order to make this happen, everyone in the clinic needs to be educated on the required clinical screenings and documentation. The case study is designed for: medical assistants, pre, post, tumor, and organ management nurses, and nurse practitioners. The case study will be reviewed over the next two

Our study included hundred treatment naïve Egyptian patients with chronic hepatitis C mono infection (67%, males and 33% females); their mean age (± SD) was 40.29 years (± 10.98). Significant fibrosis (≥ F2) was present in 62 patients, advanced fibrosis (≥ F3) was present in 24 patients and cirrhosis (F4) was present in 11 patients, other general characteristics of the study population are summarized in table 1. The mean values ± SD of Hepa-Index parameters were: Platelets count (201.58 ± 59.02 109/L)

Introduction Vitamin C, or ascorbic acid, is a well-known supplement that is essential to the human body. Vitamin C helps grow and repair body tissue, make collagen, heal wounds, and strengthen bones and teeth. Unfortunately, the body does not produce this vitamin itself, therefore it must be obtained from another source. Vitamin C is present in significant amounts in both fruits and vegetables. These foods are commonly pasteurized – a process that applies heat to destroy pathogens that cause spoilage

blood that is caused by bacteria leading to harmful diseases and viruses. Bloodborne pathogens are spread through direct or indirect contact, and respiratory or vector borne transmission. Hepatitis C is a disease of the liver that is contagious and over time can cause other harmful problems. Hepatitis C starts off as an acute infection that in many cases can become chronic if not treated right away. Medical professionals work with needles and other sharp objects that come into contact with other people

About 4.1 million people in Americans have the positive antibody to hepatitis C virus (HCV), and about 75 percent have permeant infection. Additionally, most of the infections happened 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk of severe complications in the infected people. Identification, death, and treatment are predicted to affect 35,000 by 2030. The Center for Disease Control

Main problem: Chronic Hepatitis C Hepatitis is a systemic disease primarily involving the liver, the term is used to construe inflammation of the liver. One of the main forms of Hepatitis is Hepatitis C; an RNA virus and uses liver cells to create copies of itself, killing those cells in the process. Prior to the identification of the infection in 1989 it was labelled “non-A, non-B” hepatitis (1). HCV blood-borne virus that predominantly infects the cells of the liver and advances to liver inflammation

The increasing number of citizens that are testing positive for Hepatitis C is shocking and the epidemic is just getting worse. One out of every one hundred people in the general population has Hepatitis C, but the ratio is higher in prisons. One out of every six inmates has Hepatitis C (Wegner, Rottnek, Parker and Crippin, 2014). Hepatitis C (HCV) is a blood disease that is caused by a virus and it affects the liver. Unfortunately there is no vaccine to prevent this disease and I have seen first-hand

by the contamination of food and water. Hepatitis B is mostly a sexually transmitted infection, but can also be passed from mother to baby during pregnancy or a childbirth occurrence. Both hepatitis B and hepatitis C are most usually spread through infected

Introduction The hepatitis C virus (HCV) is the most widespread blood borne infection throughout the United States. It is estimated that nearly 3.2 million Americans are chronically infected (Centers for Disease Control and Prevention, 2014). HCV is a leading cause of cirrhosis, hepatocellular carcinoma, and is an indication for liver transplant (Medscape, 2012). As a result, HCV poses a significant economic burden on the American health care system. For decades drugs given to cure HCV patients

Analysis of commercial vitamin C tablets Objective To determine the vitamin C content in commercial vitamin C tablets by titration between vitamin C (ascorbic acid) & iodine solution. Hence, compare this data with the manufacturer 's specification. Principle In this analysis, certain amount of iodine solution, which is known in excess, is added to acidified ascorbic acid solution. Brown iodine can be easily reduced by acidified ascorbic acid to form colourless iodide ion: